Moderna sees higher COVID vaccine sales in second half of 2022 - Reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/EBPSIU4CJZPJDGFG46WZDQPWFI.jpg)
5/4/2022 12:00:00 AM3 yearsago
Moderna Inc <a href="https://www.reuters.com/companies/MRNA.O" target="_blank">(MRNA.O)</a> on Wednesday reported $6 billion in first-quarter revenue from its COVID-19 vaccine that breezed past estimates, and said it expects vaccine sales to be higher in the …
May 4 (Reuters) - Moderna Inc (MRNA.O) on Wednesday reported $6 billion in first-quarter revenue from its COVID-19 vaccine that breezed past estimates, and said it expects vaccine sales to be higher … [+1984 chars]
full article...